Halozyme prices upsized USD 1.3 billion convertible senior notes offering due 2033
Halozyme priced an upsized private offering of USD 1.3 billion 1.5% convertible senior notes due 2033. Deal increased from the previously announced USD 1.05 billion size. * Initial purchasers received a 13-day option to buy up to an additional USD 200 million of the notes. Net proceeds expected at about USD 1.28 billio